Markt für Neuromodulation – Erkenntnisse aus globaler und regionaler Analyse – Prognose bis 2031

  • Report Code : TIPHE100001415
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 195
Buy Now

Der Neuromodulationsmarkt wurde 2019 auf 7.613,45 Millionen US-Dollar geschätzt und soll bis 2027 16.333,98 Millionen US-Dollar erreichen; Es wird erwartet, dass sie zwischen 2020 und 2027 mit einer durchschnittlichen jährlichen Wachstumsrate von 10,3 % wachsen wird.



Neurologische Erkrankungen wie zerebrovaskuläre Erkrankungen, Alzheimer und Parkinson können mit Hilfe der Neuromodulation behandelt werden, die mithilfe verschiedener Methoden durchgeführt wird Geräte oder Infusionen von Medikamenten. Geräte, die auf dem Neuromodulationsmarkt verwendet werden, umfassen die Anwendung von Elektroden am Rückenmark, Gehirn oder peripheren Nerven.



Lukrative Regionen auf dem Neuromodulationsmarkt



Markteinblicke



Zunehmend Das Auftreten neurologischer Erkrankungen treibt das Marktwachstum voran



Depressionen sind die häufigste neurologische Erkrankung in allen Altersgruppen. In den Entwicklungsregionen leiden die meisten Menschen aufgrund verschiedener sozioökonomischer Faktoren wie finanzieller Belastung und Armut an Depressionen. Andere neurologische Störungen wie Dystonie, Parkinson-Krankheit und Zwangsstörungen werden normalerweise in der alternden Bevölkerung beobachtet. Laut einer im Januar 2018 veröffentlichten Studie „Incidence and Prevalence of Major Neurologic Disorders“ leiden etwa 36 % der älteren Menschen in den USA an einer mittelschweren oder schweren Gedächtnisstörung. Jedes Jahr werden bei fast 1,2 Millionen Erwachsenen Gehirnstörungen diagnostiziert, von denen 51,3 % auf einen Schlaganfall und 21 % auf die Alzheimer-Krankheit zurückzuführen sind. Darüber hinaus werden jedes Jahr bei fast 135 Millionen Menschen Parkinson, traumatische Hirnverletzungen und Epilepsie diagnostiziert. Darüber hinaus werden jährlich etwa 500.000 Fälle von Hirntumor, Multipler Sklerose und Amyotropher Lateralsklerose gemeldet. Daher steigert die zunehmende Prävalenz neurologischer Erkrankungen die Nachfrage nach Neuromodulatoren, da diese zur Linderung neurologischer Symptome beitragen. Darüber hinaus steigt die Nachfrage nach Neurostimulationsgeräten zur Behandlung chronischer Schmerzen.



Produkteinblicke



Technisch gesehen hatte das Segment der externen (nicht-invasiven) Neuromodulation einen größeren Anteil an der Neuromodulation Markt im Jahr 2019. Es wird erwartet, dass das gleiche Segment seine Dominanz beibehalten und im Prognosezeitraum eine höhere CAGR auf dem Markt verzeichnen wird.



Neuromodulationsmarkt, nach Technologie – 2019 und 2027



Anwendung Erkenntnisse



Basierend auf der Anwendung ist der globale Neuromodulationsmarkt in chronische Schmerzbehandlung, Failed-Back-Syndrom, Epilepsie, Tremor, Inkontinenz, Depression, Dystonie, Gastroparese, Parkinson-Krankheit, Zwangsstörung und Migräne unterteilt. Das Segment der Behandlung chronischer Schmerzen hielt 2019 den größten Marktanteil und wird im Prognosezeitraum voraussichtlich die höchste CAGR verzeichnen.



Die Behandlung chronischer Schmerzen trägt zur Schmerzlinderung durch den Einsatz von Medikamenten, Therapien usw. bei. und Lebensstiländerungen. Elektrostimulationsgeräte spielen eine wichtige Rolle bei der Schmerzbehandlung, da sie in erster Linie zur Linderung verschiedener Arten von chronischen und akuten Schmerzen entwickelt werden. Die wachsende geriatrische Bevölkerung, die zunehmende Prävalenz chronischer Erkrankungen und ein sitzender Lebensstil sind einige der Risikofaktoren, die chronische Schmerzen verursachen können. Laut einer 2019 von der Arthritis Foundation veröffentlichten Studie ist beispielsweise die alternde Bevölkerung für die wachsende Prävalenz aller Arten von Krankheiten auf der ganzen Welt verantwortlich. In derselben Studie wurde festgestellt, dass jedes Jahr jeder Dritte in den USA an Arthritis leidet. Daher wird erwartet, dass die steigende Prävalenz chronischer Schmerzen das Wachstum des Segments im Prognosezeitraum vorantreiben wird.



Die Integration fortschrittlicher Technologien in elektrische Stimulationsgeräte ermöglicht zusätzliche Vorteile für die Schmerzbehandlung. Beispielsweise gab Abbott im Januar 2019 Testergebnisse der BurstDR-Stimulation bekannt, die zur Behandlung chronischer Schmerzen entwickelt wurde. Die Ergebnisse zeigen, dass das Produkt die Schmerzen um etwa 60–70 % lindert.



Strategische Erkenntnisse



Die auf dem Neuromodulationsmarkt tätigen Akteure verfolgen Kooperations- und Partnerschaftsstrategien, um den Anforderungen der Endbenutzer bei der Einführung gerecht zu werden von technologisch fortschrittlichen Angeboten, und diese Strategien unterstützen das Wachstum des Marktes erheblich.



Nach Technologie




  • Externe (nicht-invasive) Neuromodulation

    • Respiratorische Elektrik Stimulation

    • Transkutane elektrische Nervenstimulation

    • Transkranielle Magnetstimulation



  • Interne Neuromodulation

    • Tiefenhirnstimulation
    • Stimulation des Sakralnervs

    • Elektrostimulation des Magens

    • Stimulation des Rückenmarks

    • Stimulation des Vagusnervs




Nach Anwendung




  • Chronische Schmerzbehandlung

  • Failed-Back-Syndrom

  • Epilepsie

  • Tremor
  • Inkontinenz

  • Depression

  • Dystonie

  • Gastroparese

  • Parkinson-Krankheit

  • Zwangsstörung

  • Migräne


Nach Endbenutzer

  • Krankenhäuser

  • Kliniken

  • Häusliche Gesundheitsversorgung

Nach Geografie




  • Nordamerika

    • USA

    • Kanada

    • Mexiko


    < /li>
  • Europa

    • Frankreich

    • Deutschland

    • Italien

    • Großbritannien

    • Russland



  • Asien-Pazifik

    • China

    • Indien

    • Südkorea

    • Japan

    • < li>Australien


  • Naher Osten und Afrika

    • Südafrika

    • Saudi-Arabien

    • VAE


  • Süd- und Mittelamerika

    • Brasilien

    • Argentinien




Unternehmensprofile




  • Abbott

  • Boston Scientific Corporation

  • Medtronic

  • NeuroPace, Inc.

  • NeuroSigma , Inc.

  • NEVRO CORP.

  • Synapse Biomedical Inc.

  • Soterix Medical Inc

  • Integer Holdings Corporation

  • Magstim


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the neuromodulation?

Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or the peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation.

What are the driving factors for the neuromodulation market across the globe?

The global neuromodulation market is being driven by factors such as increasing incidence of neurological disorders, growing developments in neuromodulation technology. Furthermore, rising demand for neurostimulation devices to treat chronic pain is likely to offer significant opportunities for the growth of the global neurostimulation market.

What are the restraining factors for the neuromodulation market across the globe?

The high cost of neuromodulation devices is the significant factor that will hinder the neuromodulation market growth.

The List of Companies - Neuromodulation Market

  1. Abbott
  2. Boston Scientific Corporation
  3. Medtronic
  4. NeuroPace, Inc.
  5. NeuroSigma, Inc.
  6. NEVRO CORP.
  7. Synapse Biomedical Inc.
  8. Soterix Medical Inc
  9. Integer Holdings Corporation
  10. Magstim

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports